https://wikimd.org/index.php?action=history&feed=atom&title=Ravidasvir 2026-04-27T04:45:23Z Revision history for this page on the wiki MediaWiki 1.44.2 https://wikimd.org/index.php?title=Ravidasvir&diff=6336652&oldid=prev 2025-02-20T01:50:01Z

<p>CSV import</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 01:50, 20 February 2025</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l34">Line 34:</td> <td colspan="2" class="diff-lineno">Line 34:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Antiviral-drug-stub}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Antiviral-drug-stub}}</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{medicine-stub}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{medicine-stub}}</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">&lt;gallery&gt;</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">File:Ravidasvir.svg|Ravidasvir</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">&lt;/gallery&gt;</ins></div></td></tr> </table>

Prab https://wikimd.org/index.php?title=Ravidasvir&diff=5343163&oldid=prev 2024-03-02T14:40:22Z

<p>CSV import</p> <p><b>New page</b></p><div>&#039;&#039;&#039;Ravidasvir&#039;&#039;&#039; is an [[antiviral drug]] used in the treatment of [[Hepatitis C]]. It is a direct-acting antiviral agent (DAA) and specifically targets the [[NS5A]] protein, which is essential for the replication of the Hepatitis C virus. Ravidasvir is often used in combination with other antiviral drugs to increase the effectiveness of treatment.<br /> <br /> == Mechanism of Action ==<br /> <br /> Ravidasvir inhibits the [[NS5A]] protein, a phosphoprotein that plays a crucial role in the replication of the Hepatitis C virus. By binding to this protein, Ravidasvir prevents the virus from replicating and spreading within the body.<br /> <br /> == Clinical Use ==<br /> <br /> Ravidasvir has been used in combination with other antiviral drugs such as [[Sofosbuvir]] to treat Hepatitis C. This combination has shown high cure rates in clinical trials, even in patients with advanced liver disease or those who have previously failed other treatments.<br /> <br /> == Side Effects ==<br /> <br /> Like all medications, Ravidasvir can cause side effects. The most common side effects include fatigue, headache, and nausea. However, these side effects are usually mild and go away on their own.<br /> <br /> == Development and Approval ==<br /> <br /> Ravidasvir was developed by [[Presidio Pharmaceuticals]], a biopharmaceutical company based in San Francisco, California. It was later licensed to [[Pharco Pharmaceuticals]], an Egyptian company, for production and distribution in certain countries.<br /> <br /> In 2018, the [[World Health Organization]] prequalified Ravidasvir, making it more accessible for low- and middle-income countries.<br /> <br /> == See Also ==<br /> <br /> * [[Hepatitis C]]<br /> * [[Antiviral drug]]<br /> * [[Direct-acting antiviral agent]]<br /> * [[NS5A]]<br /> * [[Sofosbuvir]]<br /> * [[Presidio Pharmaceuticals]]<br /> * [[Pharco Pharmaceuticals]]<br /> * [[World Health Organization]]<br /> <br /> [[Category:Antiviral drugs]]<br /> [[Category:Hepatitis C]]<br /> {{Antiviral-drug-stub}}<br /> {{medicine-stub}}</div>

Prab